The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction.
Jorge A. Marrero
Consultant or Advisory Role - Bayer/Onyx
Honoraria - Bayer
Research Funding - Bayer
Riccardo Lencioni
Honoraria - Bayer Schering Pharma
Research Funding - Bayer
Sheng-Long Ye
No relevant relationships to disclose
Masatoshi Kudo
No relevant relationships to disclose
Jean-Pierre Bronowicki
Honoraria - Bayer
Research Funding - Bayer
Xiao-Ping Chen
Honoraria - Bayer
Lucy Dagher
Research Funding - Bayer
Junji Furuse
Honoraria - Bayer
Research Funding - Bayer
Jean-Francois Geschwind
Employment or Leadership Position - John Hopkins Hospital
Consultant or Advisory Role - Bayer; Biocompatibles; Delcath Systems ; Jennerex Biotherapeutics; Nordion; Philips Healthcare; Prescience Labs
Honoraria - Bayer; Biocompatibles; Delcath Systems ; Guerbet; Jennerex Biotherapeutics; Nordion; Prescience Labs
Research Funding - Bayer; Biocompatibles; Department of Defense; Guerbet; NCI-ECOG; NIH-RO1; Nordion; Philips Healthcare
Laura LadrĂ³n de Guevara
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Christos Papandreou
Honoraria - Bayer
Research Funding - Bayer
Arun J. Sanyal
Consultant or Advisory Role - Gore; Merck; Norgine; Roche; Salix Pharmaceuticals
Research Funding - Bayer/Onyx; Exalenz Bioscience; Genentech; Gilead Sciences; Intercept Pharmaceuticals; Salix Pharmaceuticals
Other Remuneration - UpToDate
Tadatoshi Takayama
Honoraria - Bayer
Research Funding - Bayer
Seung Kew Yoon
No relevant relationships to disclose
Keiko Nakajima
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Alan Paul Venook
Consultant or Advisory Role - Bayer/Onyx (U)
Research Funding - Bayer/Onyx